Cargando…

Comprehensive Assessment of Secreted Immuno-Modulatory Cytokines by Serum-Differentiated and Stem-like Glioblastoma Cells Reveals Distinct Differences between Glioblastoma Phenotypes

Glioblastoma is refractory to therapy and presents a significant oncological challenge. Promising immunotherapies have not shown the promise observed in other aggressive cancers. The reasons for this include the highly immuno-suppressive tumour microenvironment controlled by the glioblastoma cells a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robilliard, Laverne D., Yu, Jane, Anchan, Akshata, Finlay, Graeme, Angel, Catherine E., Graham, E Scott
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692434/ https://www.ncbi.nlm.nih.gov/pubmed/36430641 http://dx.doi.org/10.3390/ijms232214164

Ejemplares similares

Can ECIS Biosensor Technology Be Used to Measure the Cellular Responses of Glioblastoma Stem Cells?
por: Robilliard, Laverne Diana, et al.
Publicado: (2021)

BSBM-14 MOLECULAR PROFILING OF CHECKPOINT LIGANDS AND KEY NK-ACTIVATION AND SUPPRESSIVE LIGANDS BY METASTATIC MELANOMA CELLS
por: Anchan, Akshata, et al.
Publicado: (2023)

Analysis of Melanoma Secretome for Factors That Directly Disrupt the Barrier Integrity of Brain Endothelial Cells
por: Anchan, Akshata, et al.
Publicado: (2020)

The Importance of Multifrequency Impedance Sensing of Endothelial Barrier Formation Using ECIS Technology for the Generation of a Strong and Durable Paracellular Barrier
por: Robilliard, Laverne D., et al.
Publicado: (2018)

BSBM-13 MELANOMA CELLS PRODUCE A SUSPENSION SUB-POPULATION THAT DRASTICALLY DISRUPTS THE BLOOD-BRAIN BARRIER ENDOTHELIUM
por: Anchan, Akshata, et al.
Publicado: (2023)

Melanoma Mediated Disruption of Brain Endothelial Barrier Integrity Is Not Prevented by the Inhibition of Matrix Metalloproteinases and Proteases
por: Anchan, Akshata, et al.
Publicado: (2022)

Melanoma Cells Produce Large Vesicular-Bodies That Cause Rapid Disruption of Brain Endothelial Barrier-Integrity and Disassembly of Junctional Proteins
por: Spurling, Dayna, et al.
Publicado: (2023)

Diagnosis of Glioblastoma by Immuno-Positron Emission Tomography
por: Ruiz-López, Eduardo, et al.
Publicado: (2021)

Immune Modulatory Short Noncoding RNAs Targeting the Glioblastoma Microenvironment
por: Wei, Jun, et al.
Publicado: (2021)

Immuno-oncology: are TAM receptors in glioblastoma friends or foes?
por: Zhou, Yunxiang, et al.
Publicado: (2021)

Immuno-Modulatory Effects of Intervertebral Disc Cells
por: Bermudez-Lekerika, Paola, et al.
Publicado: (2022)

The Repression of Matrix Metalloproteinases and Cytokine Secretion in Glioblastoma by Targeting K+ Channel
por: Saadat, Farshid, et al.
Publicado: (2021)

The Immuno-Modulatory Effects of Inhibitor of Apoptosis Protein Antagonists in Cancer Immunotherapy
por: Michie, Jessica, et al.
Publicado: (2020)

Editorial: The State-of-Art in Immuno-Oncology, What to Do With Glioblastoma?
por: Cui, Xiaoteng, et al.
Publicado: (2021)

Commentary: Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy
por: Skolnik, Aaron D., et al.
Publicado: (2018)

Immuno-PET Imaging of Tumour PD-L1 Expression in Glioblastoma
por: Sharma, Gitanjali, et al.
Publicado: (2023)

IMMUNO-MODULATORY PROPERTIES OF PREBIOTICS EXTRACTED FROM vernonia amygdalina
por: IM, Ezeonu, et al.
Publicado: (2016)

Electrophile Signaling and Emerging Immuno- and Neuro-modulatory Electrophilic Pharmaceuticals
por: Poganik, Jesse R., et al.
Publicado: (2020)

Real-Time Measurement of Melanoma Cell-Mediated Human Brain Endothelial Barrier Disruption Using Electric Cell-Substrate Impedance Sensing Technology
por: Anchan, Akshata, et al.
Publicado: (2019)

Clinical Effects of Immuno-Oncology Therapy on Glioblastoma Patients: A Systematic Review
por: Najafi, Masoumeh, et al.
Publicado: (2023)

A Systems Approach to Study Immuno- and Neuro-Modulatory Properties of Antiviral Agents
por: Zusinaite, Eva, et al.
Publicado: (2018)

The changing immune system in sepsis: Is individualized immuno-modulatory therapy the answer?
por: Boomer, Jonathan S, et al.
Publicado: (2014)

Antibacterial, antioxidant and Immuno-modulatory properties in extracts of Barleria lupulina Lindl.
por: Kumari, Reshma, et al.
Publicado: (2017)

Glioblastoma Recurrence Correlates With Increased APE1 and Polarization Toward an Immuno-Suppressive Microenvironment
por: Hudson, Amanda L., et al.
Publicado: (2018)

hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines
por: Masi, A, et al.
Publicado: (2005)

The Use of Targeted Cytokines as Cancer Therapeutics in Glioblastoma
por: Sooreshjani, Moloud, et al.
Publicado: (2023)

ECIS technology reveals that monocytes isolated by CD14(+ve) selection mediate greater loss of BBB integrity than untouched monocytes, which occurs to a greater extent with IL-1β activated endothelium in comparison to TNFα
por: Kho, Dan Ting, et al.
Publicado: (2017)

Corilagin induces human glioblastoma U251 cell apoptosis by impeding activity of (immuno)proteasome
por: Qin, Xianyun, et al.
Publicado: (2021)

Immuno-Modulatory Effects of Dexamethasone in Severe COVID-19—A Swedish Cohort Study
por: Asif, Sana, et al.
Publicado: (2023)

Cytokines impact natural killer cell phenotype and functionality against glioblastoma in vitro
por: Sivonen, Minna, et al.
Publicado: (2023)

Cytokine Profile in Development of Glioblastoma in Relation to Healthy Individuals
por: Jarmuzek, Pawel, et al.
Publicado: (2023)

Diagnosis and Management of Glioblastoma: A Comprehensive Perspective
por: Gilard, Vianney, et al.
Publicado: (2021)

The Vascular Microenvironment in Glioblastoma: A Comprehensive Review
por: Mosteiro, Alejandra, et al.
Publicado: (2022)

Modulatory Effect of Chelidonium majus Extract and Its Alkaloids on LPS-Stimulated Cytokine Secretion in Human Neutrophils
por: Zielińska, Sylwia, et al.
Publicado: (2020)

Immuno-phenotyping of IDH-mutant grade 3 astrocytoma and IDH-wildtype glioblastoma reveals specific differences in cells of myeloid origin
por: Raghavan, Jayashree V., et al.
Publicado: (2021)

Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine Glioblastoma
por: Nisnboym, Michal, et al.
Publicado: (2023)

Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy – Detecting Illusive Disease, Defining Response
por: Huang, Raymond Y., et al.
Publicado: (2015)

Distinct aneuploid evolution of astrocytoma and glioblastoma during recurrence
por: Zhang, Jinsen, et al.
Publicado: (2023)

The research on the immuno-modulatory defect of Mesenchymal Stem Cell from Chronic Myeloid Leukemia patients
por: Xishan, Zhu, et al.
Publicado: (2011)

Immuno-modulatory Effect of IFN-gamma in AMD and its Role as a Possible Target for Therapy
por: Jiang, Kailun, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_35me3fsha35ls434h2ih1riib8